This page provides links to all the information about PIP implants for patients, healthcare professionals and members of the press.
Final opinion on the safety of Poly Implant Prothèse (PIP) Silicone Breast Implants (2013 update) (external link)
Final report into PIP breast implants published by expert group led by NHS Medical Director Sir Bruce (external link)
Latest advice from the NHS for women worried about PIP breast implants
Breast feeding and PIP implants
Background and chronology
MHRA toxicology testing and collection of clinical findings upon removal of the implant
Independent Healthcare Advisory Services (IHAS) (external link)
British Association of Aesthetic Plastic Surgeons (BAAPs) (external link)
NHS Choices (external link)
Press releases and statements relating to PIP implants
23 May 2014 | Press release : Final European safety report about PIP silicone breast implants is published
The Medicines and Healthcare products Regulatory Agency (MHRA) today shared the final European report about the safety of the fraudulently manufactured PIP silicone breast implants that concludes that there are no convincing medical, toxicological or other data to justify routine removal of intact PIP implants.
The Medicines and Healthcare products Regulatory Agency (MHRA) today shared a new European report that states that there is currently no convincing medical, toxicological or other data to justify the removal of intact PIP breast implants as a precautionary approach.
07 Jun 2013 | Progress report after one year on the MHRA and DH response to the recommendations of the Howe Review into Poly Implant Prothèse (PIP) breast implants
In January 2012, Earl Howe commissioned a review of the activities of the MHRA into its involvement and handling of the PIP breast implant investigations. This review was published in May 2012, and made fifteen specific recommendations for the MHRA and Department of Health (DH) to act on. This report outlines the substantial progress achieved by the MHRA and DH in addressing the recommendations of the Howe Review, as of the end March 2013.
06 Jun 2013 | Press release: New tracking system for high-risk medical devices in development as the MHRA responds to review on PIP breast implants scandal
The Medicines and Healthcare products Regulatory Agency (MHRA) today announced that four NHS trusts have committed to piloting a new tracking system for high risk medical devices that will improve the monitoring of medical devices such as breast implants, heart valves and pacemakers
04 Jun 2013 | Department for Health statement: Swedish regulatory issues report on PIP breast implants
The Medical Products Agency and the National Board of Health and Welfare in Sweden have published a report recommending the removal of PIP breast implants from patients as a precautionary measure.
The MHRA and the Department of Health have today published supporting information used in the 2010 testing of PIP breast implants. This is additional to the testing results that were announced in September 2010.